Costs of Diabetes. A Methodological Analysis of the Literature

Overview

Journal Pharmacoeconomics

Specialty Pharmacology

Date 1999 Oct 28

PMID 10538331

Citations 21

Authors

E Pagano

M Brunetti

F Tediosi

L Garattini

Affiliations

Soon will be listed here.

Abstract

Objective: To review studies on the costs of diabetes and its complications through a scheme designed specifically for assessing the quality of cost-of-illness (COI) studies.

Design And Setting: The methodology of COI studies in diabetes was analysed in order to assess the significance of quantitative results. The scheme adopted 7 items identified as the main points for discussing the methodological choices governing the results. We also used a checklist based on questions related to the 7 items.

Main Outcome Measures And Results: The answers showed that many studies appear not to give technical details, so it is hard to understand the method. Methodological choices varied widely between the studies. This is probably due to the lack of consensus on the methodology of COI studies. Based on the findings of this review, we suggest also some specific points that could help produce more reliable results on the costs of diabetes.

Conclusions: Clearly, a general consensus on COI studies is still remote, making the value of any comparison of results questionable.

Citing Articles

Methods for Estimating Avoidable Costs of Excessive Alcohol Consumption.

Gavurova B, Tarhanicova M Int J Environ Res Public Health. 2021; 18(9).

PMID: 34066994 PMC: 8125101. DOI: 10.3390/ijerph18094964.

Methodological considerations in the assessment of direct and indirect costs of back pain: A systematic scoping review.

Zemedikun D, Kigozi J, Wynne-Jones G, Guariglia A, Roberts T PLoS One. 2021; 16(5):e0251406.

PMID: 33974661 PMC: 8112645. DOI: 10.1371/journal.pone.0251406.

Prevalence and socioeconomic burden of diabetes mellitus in South Korean adults: a population-based study using administrative data.

Oh S, Ku H, Park K BMC Public Health. 2021; 21(1):548.

PMID: 33743612 PMC: 7980668. DOI: 10.1186/s12889-021-10450-3.

Economic menace of diabetes in India: a systematic review.

Oberoi S, Kansra P Int J Diabetes Dev Ctries. 2020; 40(4):464-475.

PMID: 32837090 PMC: 7299136. DOI: 10.1007/s13410-020-00838-z.

The costs of diabetes treatment in low- and middle-income countries: a systematic review.

Moucheraud C, Lenz C, Latkovic M, Wirtz V BMJ Glob Health. 2019; 4(1):e001258.

PMID: 30899566 PMC: 6407562. DOI: 10.1136/bmjgh-2018-001258.

References

Gray A, Fenn P, McGuire A . The cost of insulin-dependent diabetes mellitus (IDDM) in England and Wales. Diabet Med. 1995; 12(12):1068-76. DOI: 10.1111/j.1464-5491.1995.tb00423.x. View

Casparie A, van der Waal M . Differences in preferences between diabetic patients and diabetologists regarding quality of care: a matter of continuity and efficiency of care?. Diabet Med. 1995; 12(9):828-32. DOI: 10.1111/j.1464-5491.1995.tb02087.x. View

Buxton M, Drummond M, van Hout B, Prince R, Sheldon T, Szucs T . Modelling in economic evaluation: an unavoidable fact of life. Health Econ. 1997; 6(3):217-27. DOI: 10.1002/(sici)1099-1050(199705)6:3<217::aid-hec267>3.0.co;2-w. View

Kangas T, Aro S, Koivisto V, Salinto M, Laakso M, Reunanen A . Structure and costs of health care of diabetic patients in Finland. Diabetes Care. 1996; 19(5):494-7. DOI: 10.2337/diacare.19.5.494. View

McKendry J . Direct costs of diabetes care: a survey in Ottawa, Ontario 1986. Can J Public Health. 1989; 80(2):124-8. View

Kiberd B, Jindal K . Screening to prevent renal failure in insulin dependent diabetic patients: an economic evaluation. BMJ. 1995; 311(7020):1595-9. PMC: 2551496. DOI: 10.1136/bmj.311.7020.1595. View

Javitt J, Aiello L . Cost-effectiveness of detecting and treating diabetic retinopathy. Ann Intern Med. 1996; 124(1 Pt 2):164-9. DOI: 10.7326/0003-4819-124-1_part_2-199601011-00017. View

Olsson J, Persson U, Tollin C, Nilsson S, Melander A . Comparison of excess costs of care and production losses because of morbidity in diabetic patients. Diabetes Care. 1994; 17(11):1257-63. DOI: 10.2337/diacare.17.11.1257. View

Javitt J, Canner J, Sommer A . Cost effectiveness of current approaches to the control of retinopathy in type I diabetics. Ophthalmology. 1989; 96(2):255-64. DOI: 10.1016/s0161-6420(89)32923-x. View

10.

BRANSOME Jr E . Financing the care of diabetes mellitus in the U.S. Background, problems, and challenges. Diabetes Care. 1992; 15 Suppl 1:1-5. DOI: 10.2337/diacare.15.1.s1. View

11.

. Lifetime benefits and costs of intensive therapy as practiced in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group. JAMA. 1996; 276(17):1409-15. View

12.

Rice D . Cost-of-illness studies: fact or fiction?. Lancet. 1994; 344(8936):1519-20. DOI: 10.1016/s0140-6736(94)90342-5. View

13.

Benton G, Kerstein M . Cost effectiveness of early digit amputation in the patient with diabetes. Surg Gynecol Obstet. 1985; 161(6):523-4. View

14.

Koopmanschap M, Rutten F, van Ineveld B, van Roijen L . The friction cost method for measuring indirect costs of disease. J Health Econ. 1995; 14(2):171-89. DOI: 10.1016/0167-6296(94)00044-5. View

15.

Triomphe A, Flori Y, Costagliola D, Eschwege E . The cost of diabetes in France. Health Policy. 1987; 9(1):39-48. DOI: 10.1016/0168-8510(88)90116-9. View

16.

Davey P, Leeder S . The cost of migraine: more than just a headache?. Pharmacoeconomics. 1992; 2(1):5-7. DOI: 10.2165/00019053-199202010-00002. View

17.

Huse D, Oster G, Killen A, Lacey M, Colditz G . The economic costs of non-insulin-dependent diabetes mellitus. JAMA. 1989; 262(19):2708-13. DOI: 10.1001/jama.262.19.2708. View

18.

Korn A . Case management and quality of care for diabetic patients. Diabetes Care. 1992; 15 Suppl 1:59-61. DOI: 10.2337/diacare.15.1.s59. View

19.

Agro K, Bradley C, Mittmann N, Iskedjian M, Ilersich A, Einarson T . Sensitivity analysis in health economic and pharmacoeconomic studies. An appraisal of the literature. Pharmacoeconomics. 1996; 11(1):75-88. DOI: 10.2165/00019053-199711010-00009. View

20.

RUBIN R, Altman W, Mendelson D . Health care expenditures for people with diabetes mellitus, 1992. J Clin Endocrinol Metab. 1994; 78(4):809A-809F. DOI: 10.1210/jcem.78.4.8157701. View